SRSF10 Facilitates HCC Growth and Metastasis by Suppressing CD8+T Cell Infiltration and Targeting SRSF10 Enhances Anti-Pd-l1 Therapy
Xiangyuan Luo,Zerui Zhang,Siwen Li,Yijun Wang,Mengyu Sun,Dian Hu,Junqing Jiang,Yufei Wang,Xiaoyu Ji,Xiaoping Chen,Bixiang Zhang,Huifang Liang,Yiwei Li,Bifeng Liu,Xiao Xu,Shuai Wang,Shengjun Xu,Yongzhan Nie,Kaichun Wu,Daiming Fan,Danfei Liu,Wenjie Huang,Limin Xia
DOI: https://doi.org/10.1016/j.intimp.2023.111376
IF: 5.714
2024-01-01
International Immunopharmacology
Abstract:Background and Aims: RNA splicing is an essential step in regulating the gene posttranscriptional expression. Serine/arginine-rich splicing factors (SRSFs) are splicing regulators with vital roles in various tumors. Nevertheless, the expression patterns and functions of SRSFs in hepatocellular carcinoma (HCC) are not fully understood. Methods: Flow cytometry and immunofluorescent staining were used to determine the CD8+T cell infiltration. Orthotopic HCC model, lung metastasis model, DEN/CCl4 model, Srsf10ohep model, and Srsf10HepOE model were established to evaluate the role of SRSF10 in HCC and the efficacy of combination treatment. Results: SRSF10 was one of the most survival-relevant genes among SRSF members and was an independent prognostic factor for HCC. SRSF10 facilitated HCC growth and metastasis by suppressing CD8+T cell infiltration. Mechanistically, SRSF10 down-regulated the p53 protein by preventing the exon 6 skipping (exon 7 in mouse) mediated degradation of MDM4 transcript, thus inhibiting CD8+T cell infiltration. Elimination of CD8+T cells or overexpression of MDM4 removed the inhibitory role of SRSF10 knockdown in HCC growth and metastasis. SRSF10 also inhibited the IFN alpha/gamma signaling pathway and promoted the HIF1 alpha-mediated up-regulation of PD-L1 in HCC. Hepatocyte-specific SRSF10 deficiency alleviated the DEN/CCl4-induced HCC progression and metastasis, whereas hepatocyte-specific SRSF10 overexpression deteriorated these effects. Finally, SRSF10 knockdown enhanced the anti-PD-L1-mediated anti-tumor activity.